|
C1ORF156 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.081200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.926200E-01 |
| Normal-vs-Stage2 |
5.546800E-01 |
| Normal-vs-Stage3 |
4.058100E-03 |
| Normal-vs-Stage4 |
2.191600E-02 |
| Stage1-vs-Stage2 |
5.822800E-01 |
| Stage1-vs-Stage3 |
4.048500E-04 |
| Stage1-vs-Stage4 |
3.502200E-03 |
| Stage2-vs-Stage3 |
1.817640E-01 |
| Stage2-vs-Stage4 |
3.639400E-01 |
| Stage3-vs-Stage4 |
3.985000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.678000E-01 |
| Normal-vs-AfricanAmerican |
1.437160E-01 |
| Normal-vs-Asian |
3.615600E-02 |
| Caucasian-vs-AfricanAmerican |
4.764600E-01 |
| Caucasian-vs-Asian |
1.235640E-01 |
| AfricanAmerican-vs-Asian |
1.938360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.783180E-01 |
| Normal-vs-Female |
3.393200E-01 |
| Male-vs-Female |
6.675400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.898040E-01 |
| Normal-vs-Age(41-60Yrs) |
2.120800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.063800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.924400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.111200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.679000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.946800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.749400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.308000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.797600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.285800E-01 |
| Normal-vs-Grade 2 |
4.441000E-01 |
| Normal-vs-Grade 3 |
2.212200E-02 |
| Normal-vs-Grade 4 |
1.89272999999712E-05 |
| Grade 1-vs-Grade 2 |
8.188800E-01 |
| Grade 1-vs-Grade 3 |
1.633190E-01 |
| Grade 1-vs-Grade 4 |
1.562940E-03 |
| Grade 2-vs-Grade 3 |
9.69419999999888E-05 |
| Grade 2-vs-Grade 4 |
5.09539965776185E-10 |
| Grade 3-vs-Grade 4 |
2.123500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.129400E-01 |
| Normal-vs-ccB subtype |
1.150980E-04 |
| ccA subtype-vs-ccB subtype |
5.24450038952295E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.512190E-01 |
| Normal-vs-N1 |
6.348500E-02 |
| N0-vs-N1 |
3.003200E-01 |
|
|
